Ranitidine clearance during hemodialysis with high-flux membrane: Comparison of polysulfone and cellulose acetate hemodialyzers

European Journal of Clinical Pharmacology

Volumn 56, Issue 8, 2000, Pages 581-583

  Tsuruoka, Shuichi ^a   Sugimoto, Koh Ichi ^a   Hayasaka, Tokie ^b   Saito, Tetsuo ^b   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Moka Hospital   (Japan)

Author keywords

Hemodialyzer clearance; High flux membrane; Ranitidine

Indexed keywords

CELLULOSE ACETATE; CUPROPHANE; POLYSULFONE; RANITIDINE;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPARATIVE STUDY; DIALYSIS MEMBRANE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; FEMALE; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL;

CELLULOSE; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; POLYMERS; RANITIDINE; RENAL DIALYSIS; SULFONES;

EID: 0033671870     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000191     Document Type: Article

References (11)

1. Prevalence of Helicobacter pylori in patients with end-stage renal failure and renal transplant recipients
2. Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients
3. Ranitidine bioavailability and disposition in patients undergoing chronic hemodialysis
4. Markedly increased clearance of vancomycin during hemodialysis using polysulfone
5. Clearance of ceftriaxone during haemodialysis using cuprophane haemophane and polysulfone dialyzers
6. A high performance liquid chromatography method for the determination of ranitidine in plasma
7. The pharmacokinetics of pravastatin in patients on chronic hemodialysis
8. High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis
9. Pharmacokinetics and bioavailability of ranitidine in humans
10. Ranitidine accumulation in patients undergoing chronic hemodialysis
11. Pharmacological effective plasma concentration of ranitidine